Leguisan, Mario M.

HRN: 28-04-73  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/06/2025
METRONIDAZOLE 500MG (TAB)
11/06/2025
11/13/2025
PO
500mg
Tid
Acute Infectious Diarrhea
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominalEye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: